APO Research
Talk to an analyst

APO RESEARCH · REPORT

Omeprazole Sodium Injection (IV Drip)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Omeprazole Sodium Injection (IV Drip) Market Outlook and Growth Opportunities 2026

23 December 2025195 pages

Choose your research edition.

Industry ResearchOmeprazole Sodium Injection (IV Drip) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Omeprazole Sodium Injection (IV Drip) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Omeprazole Sodium Injection (IV Drip) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omeprazole Sodium Injection (IV Drip) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Omeprazole Sodium Injection (IV Drip) Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Omeprazole Sodium Injection (IV Drip) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Omeprazole Sodium Injection (IV Drip) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Omeprazole Sodium Injection (IV Drip) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Omeprazole Sodium Injection (IV Drip) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Omeprazole Sodium Injection (IV Drip) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Omeprazole Sodium Injection (IV Drip) market include Dexa Medica, Getz Pharma, Laboratorios Normon, AstraZeneca, Shaanxi Bosen Biological Pharmaceutical, Fuan Pharmaceutical, Harbin Medisan Pharmaceutical, Hainan Quanxing Pharmaceutical and Hunan Hengsheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Omeprazole Sodium Injection (IV Drip) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Omeprazole Sodium Injection (IV Drip) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Omeprazole Sodium Injection (IV Drip) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Omeprazole Sodium Injection (IV Drip) market size, projected growth trends, production technologies, key applications, and end-use industries.

Omeprazole Sodium Injection (IV Drip) Segment by Company

Dexa Medica

Getz Pharma

Laboratorios Normon

AstraZeneca

Shaanxi Bosen Biological Pharmaceutical

Fuan Pharmaceutical

Harbin Medisan Pharmaceutical

Hainan Quanxing Pharmaceutical

Hunan Hengsheng Pharmaceutical

North China Pharmaceutical

Kelun Pharmaceutical

Luoxin PharmaceuticaIs

Humanwell Healthcare

Sailong Pharmaceutical

Zhejiang Yatai Pharmaceutical

Omeprazole Sodium Injection (IV Drip) Segment by Type

20mg

40mg

Others

Omeprazole Sodium Injection (IV Drip) Segment by Application

Hospital

Clinic

Others

Omeprazole Sodium Injection (IV Drip) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Omeprazole Sodium Injection (IV Drip) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Omeprazole Sodium Injection (IV Drip) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Omeprazole Sodium Injection (IV Drip) significant trends, drivers, influence factors in global and regions.

6. To analyze Omeprazole Sodium Injection (IV Drip) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omeprazole Sodium Injection (IV Drip) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omeprazole Sodium Injection (IV Drip) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omeprazole Sodium Injection (IV Drip).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Omeprazole Sodium Injection (IV Drip) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Omeprazole Sodium Injection (IV Drip) industry.

Chapter 3: Detailed analysis of Omeprazole Sodium Injection (IV Drip) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Omeprazole Sodium Injection (IV Drip) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Omeprazole Sodium Injection (IV Drip) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Omeprazole Sodium Injection (IV Drip) Industry Trends Table 2. Omeprazole Sodium Injection (IV Drip) Industry Drivers Table 3. Omeprazole Sodium Injection (IV Drip) Industry Opportunities and Challenges Table 4. Omeprazole Sodium Injection (IV Drip) Industry Restraints Table 5. Global Omeprazole Sodium Injection (IV Drip) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Omeprazole Sodium Injection (IV Drip) Revenue Share by Company (2021-2026) Table 7. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Company (2021-2026) Table 9. Global Omeprazole Sodium Injection (IV Drip) Average Price (USD/unit) of Company (2021-2026) Table 10. Global Omeprazole Sodium Injection (IV Drip) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Omeprazole Sodium Injection (IV Drip) Key Company Manufacturing Base & Headquarters Table 12. Global Omeprazole Sodium Injection (IV Drip) Company, Product Type & Application Table 13. Global Omeprazole Sodium Injection (IV Drip) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Omeprazole Sodium Injection (IV Drip) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20mg Table 18. Significant Companies of 40mg Table 19. Significant Companies of Others Table 20. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Type (2021-2026) & (k units) Table 22. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Type (2027-2032) & (k units) Table 23. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Type (2021-2026) Table 24. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Type (2027-2032) Table 25. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type (2021-2026) Table 29. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Others Table 33. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Application (2021-2026) & (k units) Table 35. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Application (2027-2032) & (k units) Table 36. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Application (2021-2026) Table 37. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Application (2027-2032) Table 38. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application (2021-2026) Table 42. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application (2027-2032) Table 43. Global Omeprazole Sodium Injection (IV Drip) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Omeprazole Sodium Injection (IV Drip) Sales by Region (2021-2026) & (k units) Table 45. Global Omeprazole Sodium Injection (IV Drip) Sales Market Share by Region (2021-2026) Table 46. Global Omeprazole Sodium Injection (IV Drip) Sales by Region (2027-2032) & (k units) Table 47. Global Omeprazole Sodium Injection (IV Drip) Sales Market Share by Region (2027-2032) Table 48. Global Omeprazole Sodium Injection (IV Drip) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Region (2021-2026) Table 51. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Region (2027-2032) Table 53. Global Omeprazole Sodium Injection (IV Drip) Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Omeprazole Sodium Injection (IV Drip) Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Omeprazole Sodium Injection (IV Drip) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Omeprazole Sodium Injection (IV Drip) Sales by Country (2021-2026) & (k units) Table 58. Global Omeprazole Sodium Injection (IV Drip) Sales Market Share by Country (2021-2026) Table 59. Global Omeprazole Sodium Injection (IV Drip) Sales by Country (2027-2032) & (k units) Table 60. Global Omeprazole Sodium Injection (IV Drip) Sales Market Share by Country (2027-2032) Table 61. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Omeprazole Sodium Injection (IV Drip) Sales Value Market Share by Country (2021-2026) Table 63. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Omeprazole Sodium Injection (IV Drip) Sales Value Market Share by Country (2027-2032) Table 65. Dexa Medica Company Information Table 66. Dexa Medica Business Overview Table 67. Dexa Medica Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Dexa Medica Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 69. Dexa Medica Recent Development Table 70. Getz Pharma Company Information Table 71. Getz Pharma Business Overview Table 72. Getz Pharma Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Getz Pharma Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 74. Getz Pharma Recent Development Table 75. Laboratorios Normon Company Information Table 76. Laboratorios Normon Business Overview Table 77. Laboratorios Normon Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Laboratorios Normon Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 79. Laboratorios Normon Recent Development Table 80. AstraZeneca Company Information Table 81. AstraZeneca Business Overview Table 82. AstraZeneca Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. AstraZeneca Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 84. AstraZeneca Recent Development Table 85. Shaanxi Bosen Biological Pharmaceutical Company Information Table 86. Shaanxi Bosen Biological Pharmaceutical Business Overview Table 87. Shaanxi Bosen Biological Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Shaanxi Bosen Biological Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 89. Shaanxi Bosen Biological Pharmaceutical Recent Development Table 90. Fuan Pharmaceutical Company Information Table 91. Fuan Pharmaceutical Business Overview Table 92. Fuan Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Fuan Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 94. Fuan Pharmaceutical Recent Development Table 95. Harbin Medisan Pharmaceutical Company Information Table 96. Harbin Medisan Pharmaceutical Business Overview Table 97. Harbin Medisan Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Harbin Medisan Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 99. Harbin Medisan Pharmaceutical Recent Development Table 100. Hainan Quanxing Pharmaceutical Company Information Table 101. Hainan Quanxing Pharmaceutical Business Overview Table 102. Hainan Quanxing Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Hainan Quanxing Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 104. Hainan Quanxing Pharmaceutical Recent Development Table 105. Hunan Hengsheng Pharmaceutical Company Information Table 106. Hunan Hengsheng Pharmaceutical Business Overview Table 107. Hunan Hengsheng Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Hunan Hengsheng Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 109. Hunan Hengsheng Pharmaceutical Recent Development Table 110. North China Pharmaceutical Company Information Table 111. North China Pharmaceutical Business Overview Table 112. North China Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. North China Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 114. North China Pharmaceutical Recent Development Table 115. Kelun Pharmaceutical Company Information Table 116. Kelun Pharmaceutical Business Overview Table 117. Kelun Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Kelun Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 119. Kelun Pharmaceutical Recent Development Table 120. Luoxin PharmaceuticaIs Company Information Table 121. Luoxin PharmaceuticaIs Business Overview Table 122. Luoxin PharmaceuticaIs Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Luoxin PharmaceuticaIs Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 124. Luoxin PharmaceuticaIs Recent Development Table 125. Humanwell Healthcare Company Information Table 126. Humanwell Healthcare Business Overview Table 127. Humanwell Healthcare Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Humanwell Healthcare Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 129. Humanwell Healthcare Recent Development Table 130. Sailong Pharmaceutical Company Information Table 131. Sailong Pharmaceutical Business Overview Table 132. Sailong Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Sailong Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 134. Sailong Pharmaceutical Recent Development Table 135. Zhejiang Yatai Pharmaceutical Company Information Table 136. Zhejiang Yatai Pharmaceutical Business Overview Table 137. Zhejiang Yatai Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Zhejiang Yatai Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio Table 139. Zhejiang Yatai Pharmaceutical Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Omeprazole Sodium Injection (IV Drip) Distributors List Table 143. Omeprazole Sodium Injection (IV Drip) Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Omeprazole Sodium Injection (IV Drip) Product Image Figure 2. Global Omeprazole Sodium Injection (IV Drip) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Omeprazole Sodium Injection (IV Drip) Sales (2021-2032) & (k units) Figure 5. Global Omeprazole Sodium Injection (IV Drip) Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Omeprazole Sodium Injection (IV Drip) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20mg Image Figure 10. 40mg Image Figure 11. Others Image Figure 12. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Type (2021-2032) Figure 15. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Application (2021-2032) Figure 24. Global Omeprazole Sodium Injection (IV Drip) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application (2021-2032) Figure 27. Global Omeprazole Sodium Injection (IV Drip) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Omeprazole Sodium Injection (IV Drip) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Omeprazole Sodium Injection (IV Drip) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Omeprazole Sodium Injection (IV Drip) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Omeprazole Sodium Injection (IV Drip) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 20mg
  • 40mg
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Dexa Medica
  • Getz Pharma
  • Laboratorios Normon
  • AstraZeneca
  • Shaanxi Bosen Biological Pharmaceutical
  • Fuan Pharmaceutical
  • Harbin Medisan Pharmaceutical
  • Hainan Quanxing Pharmaceutical
  • Hunan Hengsheng Pharmaceutical
  • North China Pharmaceutical
  • Kelun Pharmaceutical
  • Luoxin PharmaceuticaIs
  • Humanwell Healthcare
  • Sailong Pharmaceutical
  • Zhejiang Yatai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032)
  4. 1.2.2 Global Omeprazole Sodium Injection (IV Drip) Sales Volume (2021-2032)
  5. 1.2.3 Global Omeprazole Sodium Injection (IV Drip) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Omeprazole Sodium Injection (IV Drip) Market Dynamics
  1. 2.1 Omeprazole Sodium Injection (IV Drip) Industry Trends
  2. 2.2 Omeprazole Sodium Injection (IV Drip) Industry Drivers
  3. 2.3 Omeprazole Sodium Injection (IV Drip) Industry Opportunities and Challenges
  4. 2.4 Omeprazole Sodium Injection (IV Drip) Industry Restraints
3 Omeprazole Sodium Injection (IV Drip) Market by Company
  1. 3.1 Global Omeprazole Sodium Injection (IV Drip) Company Revenue Ranking in 2025
  2. 3.2 Global Omeprazole Sodium Injection (IV Drip) Revenue by Company (2021-2026)
  3. 3.3 Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Company (2021-2026)
  4. 3.4 Global Omeprazole Sodium Injection (IV Drip) Average Price by Company (2021-2026)
  5. 3.5 Global Omeprazole Sodium Injection (IV Drip) Company Ranking (2024-2026)
  6. 3.6 Global Omeprazole Sodium Injection (IV Drip) Company Manufacturing Base and Headquarters
  7. 3.7 Global Omeprazole Sodium Injection (IV Drip) Company Product Type and Application
  8. 3.8 Global Omeprazole Sodium Injection (IV Drip) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Omeprazole Sodium Injection (IV Drip) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Omeprazole Sodium Injection (IV Drip) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Omeprazole Sodium Injection (IV Drip) Market by Type
  1. 4.1 Omeprazole Sodium Injection (IV Drip) Type Introduction
  2. 4.1.1 20mg
  3. 4.1.2 40mg
  4. 4.1.3 Others
  5. 4.2 Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Type
  6. 4.2.1 Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Type
  10. 4.3.1 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type (2021-2032)
5 Omeprazole Sodium Injection (IV Drip) Market by Application
  1. 5.1 Omeprazole Sodium Injection (IV Drip) Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Application
  6. 5.2.1 Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Omeprazole Sodium Injection (IV Drip) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Omeprazole Sodium Injection (IV Drip) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Application
  10. 5.3.1 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application (2021-2032)
6 Omeprazole Sodium Injection (IV Drip) Regional Sales and Value Analysis
  1. 6.1 Global Omeprazole Sodium Injection (IV Drip) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Omeprazole Sodium Injection (IV Drip) Sales by Region (2021-2032)
  3. 6.2.1 Global Omeprazole Sodium Injection (IV Drip) Sales by Region: 2021-2026
  4. 6.2.2 Global Omeprazole Sodium Injection (IV Drip) Sales by Region (2027-2032)
  5. 6.3 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Region (2027-2032)
  9. 6.5 Global Omeprazole Sodium Injection (IV Drip) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032)
  12. 6.6.2 North America Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032)
  15. 6.7.2 Europe Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032)
  21. 6.9.2 South America Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Omeprazole Sodium Injection (IV Drip) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Omeprazole Sodium Injection (IV Drip) Sales Value Share by Country, 2025 VS 2032
7 Omeprazole Sodium Injection (IV Drip) Country-level Sales and Value Analysis
  1. 7.1 Global Omeprazole Sodium Injection (IV Drip) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Omeprazole Sodium Injection (IV Drip) Sales by Country (2021-2032)
  4. 7.3.1 Global Omeprazole Sodium Injection (IV Drip) Sales by Country (2021-2026)
  5. 7.3.2 Global Omeprazole Sodium Injection (IV Drip) Sales by Country (2027-2032)
  6. 7.4 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Omeprazole Sodium Injection (IV Drip) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Omeprazole Sodium Injection (IV Drip) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Omeprazole Sodium Injection (IV Drip) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Omeprazole Sodium Injection (IV Drip) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Dexa Medica
  2. 8.1.1 Dexa Medica Company Information
  3. 8.1.2 Dexa Medica Business Overview
  4. 8.1.3 Dexa Medica Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Dexa Medica Omeprazole Sodium Injection (IV Drip) Product Portfolio
  6. 8.1.5 Dexa Medica Recent Developments
  7. 8.2 Getz Pharma
  8. 8.2.1 Getz Pharma Company Information
  9. 8.2.2 Getz Pharma Business Overview
  10. 8.2.3 Getz Pharma Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Getz Pharma Omeprazole Sodium Injection (IV Drip) Product Portfolio
  12. 8.2.5 Getz Pharma Recent Developments
  13. 8.3 Laboratorios Normon
  14. 8.3.1 Laboratorios Normon Company Information
  15. 8.3.2 Laboratorios Normon Business Overview
  16. 8.3.3 Laboratorios Normon Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Laboratorios Normon Omeprazole Sodium Injection (IV Drip) Product Portfolio
  18. 8.3.5 Laboratorios Normon Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Omeprazole Sodium Injection (IV Drip) Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Shaanxi Bosen Biological Pharmaceutical
  26. 8.5.1 Shaanxi Bosen Biological Pharmaceutical Company Information
  27. 8.5.2 Shaanxi Bosen Biological Pharmaceutical Business Overview
  28. 8.5.3 Shaanxi Bosen Biological Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shaanxi Bosen Biological Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  30. 8.5.5 Shaanxi Bosen Biological Pharmaceutical Recent Developments
  31. 8.6 Fuan Pharmaceutical
  32. 8.6.1 Fuan Pharmaceutical Company Information
  33. 8.6.2 Fuan Pharmaceutical Business Overview
  34. 8.6.3 Fuan Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Fuan Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  36. 8.6.5 Fuan Pharmaceutical Recent Developments
  37. 8.7 Harbin Medisan Pharmaceutical
  38. 8.7.1 Harbin Medisan Pharmaceutical Company Information
  39. 8.7.2 Harbin Medisan Pharmaceutical Business Overview
  40. 8.7.3 Harbin Medisan Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Harbin Medisan Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  42. 8.7.5 Harbin Medisan Pharmaceutical Recent Developments
  43. 8.8 Hainan Quanxing Pharmaceutical
  44. 8.8.1 Hainan Quanxing Pharmaceutical Company Information
  45. 8.8.2 Hainan Quanxing Pharmaceutical Business Overview
  46. 8.8.3 Hainan Quanxing Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hainan Quanxing Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  48. 8.8.5 Hainan Quanxing Pharmaceutical Recent Developments
  49. 8.9 Hunan Hengsheng Pharmaceutical
  50. 8.9.1 Hunan Hengsheng Pharmaceutical Company Information
  51. 8.9.2 Hunan Hengsheng Pharmaceutical Business Overview
  52. 8.9.3 Hunan Hengsheng Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hunan Hengsheng Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  54. 8.9.5 Hunan Hengsheng Pharmaceutical Recent Developments
  55. 8.10 North China Pharmaceutical
  56. 8.10.1 North China Pharmaceutical Company Information
  57. 8.10.2 North China Pharmaceutical Business Overview
  58. 8.10.3 North China Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 North China Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  60. 8.10.5 North China Pharmaceutical Recent Developments
  61. 8.11 Kelun Pharmaceutical
  62. 8.11.1 Kelun Pharmaceutical Company Information
  63. 8.11.2 Kelun Pharmaceutical Business Overview
  64. 8.11.3 Kelun Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Kelun Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  66. 8.11.5 Kelun Pharmaceutical Recent Developments
  67. 8.12 Luoxin PharmaceuticaIs
  68. 8.12.1 Luoxin PharmaceuticaIs Company Information
  69. 8.12.2 Luoxin PharmaceuticaIs Business Overview
  70. 8.12.3 Luoxin PharmaceuticaIs Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Luoxin PharmaceuticaIs Omeprazole Sodium Injection (IV Drip) Product Portfolio
  72. 8.12.5 Luoxin PharmaceuticaIs Recent Developments
  73. 8.13 Humanwell Healthcare
  74. 8.13.1 Humanwell Healthcare Company Information
  75. 8.13.2 Humanwell Healthcare Business Overview
  76. 8.13.3 Humanwell Healthcare Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Humanwell Healthcare Omeprazole Sodium Injection (IV Drip) Product Portfolio
  78. 8.13.5 Humanwell Healthcare Recent Developments
  79. 8.14 Sailong Pharmaceutical
  80. 8.14.1 Sailong Pharmaceutical Company Information
  81. 8.14.2 Sailong Pharmaceutical Business Overview
  82. 8.14.3 Sailong Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sailong Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  84. 8.14.5 Sailong Pharmaceutical Recent Developments
  85. 8.15 Zhejiang Yatai Pharmaceutical
  86. 8.15.1 Zhejiang Yatai Pharmaceutical Company Information
  87. 8.15.2 Zhejiang Yatai Pharmaceutical Business Overview
  88. 8.15.3 Zhejiang Yatai Pharmaceutical Omeprazole Sodium Injection (IV Drip) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Zhejiang Yatai Pharmaceutical Omeprazole Sodium Injection (IV Drip) Product Portfolio
  90. 8.15.5 Zhejiang Yatai Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Omeprazole Sodium Injection (IV Drip) Value Chain Analysis
  2. 9.1.1 Omeprazole Sodium Injection (IV Drip) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Omeprazole Sodium Injection (IV Drip) Sales Mode & Process
  6. 9.2 Omeprazole Sodium Injection (IV Drip) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Omeprazole Sodium Injection (IV Drip) Distributors
  9. 9.2.3 Omeprazole Sodium Injection (IV Drip) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst